In this section you will find information products, including market research, covering technologies in the global biotechnology industry, including company profiles, market data and information covering Europe, the UK, North America and Asia.

Stay up-to-date with new products added to this category »

Results 1 - 30 of 176
1
2
3
4
5
6

Title	Publication Date	Price
Analysis of the Anticoagulant Market	December 2011	£3795
Tradjenta (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
Bydureon (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
Humulin (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
Dapagliflozin (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
Syncria (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
Insulin Degludec (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
Actos (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
ASP1941 (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
Lantus (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
LY2189265 (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
Welchol (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
Prandin (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
Lyxumia (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
Kombiglyze XR (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
Precose (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
Levemir (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
Glyset (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
Basen (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
Symlin (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
Galvus (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
Cycloset (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
BI 10773 (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
Canagliflozin (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
Apidra (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
Glipizide (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
Humalog (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
Glyburide (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
Amaryl (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265
Avandia (Type 2 Diabetes) – Analysis and Forecasts to 2020	October 2011	£1265

Results 1 - 30 of 176
1
2
3
4
5
6

Receive latest news